121 related articles for article (PubMed ID: 23240172)
1. Experience of vaccination against invasive bacterial diseases in Veneto region (north east Italy).
Russo F; Pozza F; Napoletano G; Zanella F; Baldovin T; Lazzari R; Cocchio S; Baldo V
J Prev Med Hyg; 2012 Jun; 53(2):113-5. PubMed ID: 23240172
[TBL] [Abstract][Full Text] [Related]
2. Invasive bacterial diseases: national surveillance in Italy and vaccination coverage in the Local Health Agency 4 "Chiavarese", Liguria region (Italy).
Trucchi C; Zoppi G
J Prev Med Hyg; 2012 Jun; 53(2):120-4. PubMed ID: 23240174
[TBL] [Abstract][Full Text] [Related]
3. Prevention of invasive diseases: strategies to increase vaccination coverage in children and adolescents.
Zoppi G; Trucchi C
J Prev Med Hyg; 2012 Jun; 53(2):125-9. PubMed ID: 23240175
[TBL] [Abstract][Full Text] [Related]
4. Vaccine Impact on Long-term Trends in Invasive Bacterial Disease in New Zealand Children.
Walls T; Cho V; Martin N; Williman J; Brunton C
Pediatr Infect Dis J; 2018 Oct; 37(10):1041-1047. PubMed ID: 30222697
[TBL] [Abstract][Full Text] [Related]
5. [Advances in vaccines and invasive disease in children].
Moraga Llop FA
Rev Esp Quimioter; 2001 Dec; 14(4):319-30. PubMed ID: 11856977
[No Abstract] [Full Text] [Related]
6. Combined Haemophilus Influenzae type B-Neisseria meningitidis serogroup C vaccine is immunogenic and well tolerated in preterm infants when coadministered with other routinely recommended vaccines.
Omeñaca F; Arístegui J; Tejedor JC; Moreno-Perez D; Ruiz-Contreras J; Merino JM; Muro Brussi M; Sánchez-Tamayo T; Castro Fernandez J; Cabanillas L; Peddiraju K; Mesaros N; Miller JM
Pediatr Infect Dis J; 2011 Nov; 30(11):e216-24. PubMed ID: 21747321
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of vaccine-preventable invasive diseases in Catalonia in the era of conjugate vaccines.
Ciruela P; Martínez A; Izquierdo C; Hernández S; Broner S; Muñoz-Almagro C; Domínguez À;
Hum Vaccin Immunother; 2013 Mar; 9(3):681-91. PubMed ID: 23303166
[TBL] [Abstract][Full Text] [Related]
8. [Conjugated vaccines].
Swennen B; Sternon J
Rev Med Brux; 2002 Jun; 23(3):165-74. PubMed ID: 12143156
[TBL] [Abstract][Full Text] [Related]
9. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP;
Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296
[TBL] [Abstract][Full Text] [Related]
10. Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy.
Bechini A; Levi M; Boccalini S; Tiscione E; Balocchini E; Canessa C; Azzari C; Bonanni P
Vaccine; 2012 Oct; 30(45):6396-401. PubMed ID: 22921931
[TBL] [Abstract][Full Text] [Related]
11. A new combination haemophilus influenzae type B and Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine for primary immunization of infants.
Pace D; Snape M; Westcar S; Hamaluba M; Yu LM; Begg N; Wysocki J; Czajka H; Maechler G; Boutriau D; Pollard AJ
Pediatr Infect Dis J; 2007 Nov; 26(11):1057-9. PubMed ID: 17984816
[TBL] [Abstract][Full Text] [Related]
12. [Acceptance of the new conjugate vaccines. Meningococcal and pneumococcal vaccines, in the cohort born in 1999, in the North Region of Portugal].
De Queirós L; Castro L; Ferreira MC; Gonçalves G
Acta Med Port; 2004; 17(1):49-53. PubMed ID: 15636727
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
[TBL] [Abstract][Full Text] [Related]
14. [Survey on vaccination strategies used in different Italian Regions, for the 7-valent conjugate pneumococcal, meningococcal C and varicella vaccines].
D'Ancona F; Alfonsi V; Ciofi degli Atti ML
Ig Sanita Pubbl; 2006; 62(5):483-92. PubMed ID: 17206224
[TBL] [Abstract][Full Text] [Related]
15. Haemophilus, meningococcus and pneumococcus: comparative epidemiologic patterns of disease.
Hausdorff W
Int J Clin Pract Suppl; 2001 Feb; (118):2-4. PubMed ID: 11715360
[No Abstract] [Full Text] [Related]
16. Population-based incidence of invasive haemophilus influenzae and pneumococcal diseases before the introduction of vaccines in Japan.
Nakamura R; Togashi T
Pediatr Infect Dis J; 2013 Dec; 32(12):1394-6. PubMed ID: 23804122
[TBL] [Abstract][Full Text] [Related]
17. Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy.
Alfonsi V; D'Ancona F; Giambi C; Nacca G; Rota MC;
Health Policy; 2011 Dec; 103(2-3):176-83. PubMed ID: 22030308
[TBL] [Abstract][Full Text] [Related]
18. Impact of non-routine vaccination on the incidence of invasive Haemophilus influenzae type b (Hib) disease: experience in the autonomous region of Valencia, Spain.
Díez-Domingo J; Pereiró I; Morant A; Gimeno C; San-Martín M; González A;
J Infect; 2001 May; 42(4):257-60. PubMed ID: 11545568
[TBL] [Abstract][Full Text] [Related]
19. Present situation and new perspectives for vaccination against Neisseria meningitidis in Tuscany, Central Italy.
Bechini A; Levi M; Boccalini S; Tiscione E; Ceccherini V; Taddei C; Balocchini E; Bonanni P
J Prev Med Hyg; 2012 Jun; 53(2):61-7. PubMed ID: 23240162
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
